These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 32224756)

  • 21. Cryptogenic Stroke: Diagnostic Workup and Management.
    Mac Grory B; Flood SP; Apostolidou E; Yaghi S
    Curr Treat Options Cardiovasc Med; 2019 Dec; 21(11):77. PubMed ID: 31792625
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of antithrombotic strategies in patients with cryptogenic stroke and patent foramen ovale: an updated meta-analysis.
    Angelini F; Fortuni F; Tsivgoulis G; Agnelli G; Bocchino PP; Franchin L; De Filippo O; Bellettini M; D'Ascenzo F; Crimi G; Leonardi S; De Ferrari GM; Paciaroni M
    Cardiovasc Drugs Ther; 2021 Oct; 35(5):987-993. PubMed ID: 32918655
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Transcatheter Closure of Patent Foramen Ovale versus Medical Therapy after Cryptogenic Stroke: A Meta-Analysis of Randomized Controlled Trials.
    Darmoch F; Al-Khadra Y; Soud M; Fanari Z; Alraies MC
    Cerebrovasc Dis; 2018; 45(3-4):162-169. PubMed ID: 29597192
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Recurrent Stroke Reduction with Patent Foramen Ovale Closure versus Medical Therapy Based on Patent Foramen Ovale Characteristics: A Meta-Analysis of Randomized Controlled Trials.
    Garg A; Thawabi M; Rout A; Sossou C; Cohen M; Kostis JB
    Cardiology; 2019; 144(1-2):40-49. PubMed ID: 31574522
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cryptogenic stroke.
    Fonseca AC; Ferro JM
    Eur J Neurol; 2015 Apr; 22(4):618-23. PubMed ID: 25597418
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Closure of patent foramen ovale or medical therapy alone for secondary prevention of cryptogenic cerebrovascular events.
    Fortuni F; Crimi G; Leonardi S; Angelini F; Raisaro A; Lanzarini LF; Oltrona Visconti L; Ferrario M; De Ferrari GM
    J Cardiovasc Med (Hagerstown); 2018 Jul; 19(7):373-381. PubMed ID: 29708911
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical outcomes of secondary prevention strategies for young patients with cryptogenic stroke and patent foramen ovale.
    Danese A; Stegagno C; Tomelleri G; Piccoli A; Turri G; Carletti M; Variola A; Anselmi M; Mazzucco S; Ferrara A; Bovi P; Micheletti N; Cappellari M; Monaco S; Vassanelli C; Ribichini F;
    Acta Cardiol; 2017 Aug; 72(4):410-418. PubMed ID: 28705105
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Examining the evidence for PFO closure and novel oral anticoagulants for treatment of cryptogenic stroke.
    Khan R
    Expert Rev Cardiovasc Ther; 2020 Mar; 18(3):139-148. PubMed ID: 32085690
    [No Abstract]   [Full Text] [Related]  

  • 29. Patent Foramen Ovale Closure for Secondary Prevention of Cryptogenic Stroke: Updated Meta-Analysis of Randomized Clinical Trials.
    Vaduganathan M; Qamar A; Gupta A; Bajaj N; Golwala HB; Pandey A; Bhatt DL
    Am J Med; 2018 May; 131(5):575-577. PubMed ID: 29229471
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Current perspectives on the clinical management of cryptogenic stroke.
    Yang D; Elkind MSV
    Expert Rev Neurother; 2023 Mar; 23(3):213-226. PubMed ID: 36934333
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Embolic Stroke of Undetermined Source: JACC Review Topic of the Week.
    Ntaios G
    J Am Coll Cardiol; 2020 Jan; 75(3):333-340. PubMed ID: 31976872
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antithrombotic Treatment in Cryptogenic Stroke Patients With Patent Foramen Ovale: Systematic Review and Meta-Analysis.
    Sagris D; Georgiopoulos G; Perlepe K; Pateras K; Korompoki E; Makaritsis K; Vemmos K; Milionis H; Ntaios G
    Stroke; 2019 Nov; 50(11):3135-3140. PubMed ID: 31547797
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long-Term Follow-Up After Closure of Patent Foramen Ovale in Patients With Cryptogenic Embolism.
    Wintzer-Wehekind J; Alperi A; Houde C; Côté JM; Asmarats L; Côté M; Rodés-Cabau J
    J Am Coll Cardiol; 2019 Jan; 73(3):278-287. PubMed ID: 30678757
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cryptogenic Stroke and Patent Foramen Ovale Risk Assessment.
    Melkumova E; Thaler DE
    Interv Cardiol Clin; 2017 Oct; 6(4):487-493. PubMed ID: 28886840
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Secondary prevention of cryptogenic stroke in patients with patent foramen ovale: a systematic review and meta-analysis.
    Fiorelli EM; Carandini T; Gagliardi D; Bozzano V; Bonzi M; Tobaldini E; Comi GP; Scarpini EA; Montano N; Solbiati M
    Intern Emerg Med; 2018 Dec; 13(8):1287-1303. PubMed ID: 30032341
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Embolic stroke of undetermined source].
    Vinogradov OI; Jablonskij MA; Kuznecov AN
    Zh Nevrol Psikhiatr Im S S Korsakova; 2020; 120(12. Vyp. 2):42-48. PubMed ID: 33449532
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A meta-analysis of transcatheter closure of patent foramen ovale versus medical therapy for prevention of recurrent thromboembolic events in patients with cryptogenic cerebrovascular events.
    Pineda AM; Nascimento FO; Yang SC; Kirtane AJ; Sommer RJ; Beohar N
    Catheter Cardiovasc Interv; 2013 Nov; 82(6):968-75. PubMed ID: 23832613
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Is Patent Foramen Ovale Closure More Effective Than Medical Therapy in Preventing Stroke Recurrence in Patients With Cryptogenic Stroke?: A Critically Appraised Topic.
    Valencia-Sanchez C; Fortuin FD; Sweeney JP; Ingall TJ; Marks LA; Wingerchuk DM; O'Carroll CB
    Neurologist; 2018 Sep; 23(5):175-180. PubMed ID: 30169372
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long-term outcomes of patent foramen ovale closure or medical therapy after cryptogenic stroke: A meta-analysis of randomized trials.
    Abdelaziz HK; Saad M; Abuomara HZ; Nairooz R; Pothineni NVK; Madmani ME; Roberts DH; Mahmud E
    Catheter Cardiovasc Interv; 2018 Jul; 92(1):176-186. PubMed ID: 29726616
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Updates in the Management of Cryptogenic Stroke and Patent Foramen Ovale.
    Stone DK; Buchwald N; Wilson CA
    J Neuroophthalmol; 2020 Mar; 40(1):60-66. PubMed ID: 31996589
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.